Zimmer Biomet

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Zimmer Biomet and other ETFs, options, and stocks.

About ZBH

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. 

CEO
Ivan Tornos
CEOIvan Tornos
Employees
17,000
Employees17,000
Headquarters
Warsaw, Indiana
HeadquartersWarsaw, Indiana
Founded
1927
Founded1927
Employees
17,000
Employees17,000

ZBH Key Statistics

Market cap
17.00B
Market cap17.00B
Price-Earnings ratio
21.28
Price-Earnings ratio21.28
Dividend yield
1.12%
Dividend yield1.12%
Average volume
2.62M
Average volume2.62M
High today
$86.11
High today$86.11
Low today
$84.93
Low today$84.93
Open price
$85.60
Open price$85.60
Volume
476.51K
Volume476.51K
52 Week high
$114.44
52 Week high$114.44
52 Week low
$84.93
52 Week low$84.93

Stock Snapshot

With a market cap of 17B, Zimmer Biomet(ZBH) trades at $85.77. The stock has a price-to-earnings ratio of 21.28 and currently yields dividends of 1.1%.

As of 2026-01-28, Zimmer Biomet(ZBH) stock has fluctuated between $84.93 and $86.11. The current price stands at $85.77, placing the stock +1.0% above today's low and -0.4% off the high.

The Zimmer Biomet(ZBH)'s current trading volume is 476.51K, compared to an average daily volume of 2.62M.

In the last year, Zimmer Biomet(ZBH) shares hit a 52-week high of $114.44 and a 52-week low of $84.93.

In the last year, Zimmer Biomet(ZBH) shares hit a 52-week high of $114.44 and a 52-week low of $84.93.

ZBH News

TipRanks 4h
Zimmer Biomet price target lowered to $86 from $88 at UBS

UBS lowered the firm’s price target on Zimmer Biomet (ZBH) to $86 from $88 and keeps a Sell rating on the shares. Published first on TheFly – the ultimate sour...

Simply Wall St 6h
Is Zimmer Biomet Pricing Reflect Long Term Value After Multi Year Share Price Slide

Investors may be wondering whether Zimmer Biomet Holdings' current share price reflects its underlying value, or if the recent weakness has pushed it into poten...

Is Zimmer Biomet Pricing Reflect Long Term Value After Multi Year Share Price Slide
TipRanks 2d
Zimmer Biomet assumed at Buy from Hold at TD Cowen

TD Cowen analyst Mathew Blackman upgraded Zimmer Biomet (ZBH) to Buy from Hold with a price target of $109, up from $99, as the analyst took over coverage of th...

Analyst ratings

58%

of 31 ratings
Buy
32.3%
Hold
58.1%
Sell
9.7%

More ZBH News

Simply Wall St 3d
Zimmer Biomet Holdings Valuation After Cautious Outlook Cuts And Rising Legal And Demand Concerns

Zimmer Biomet Holdings (ZBH) is back in focus after management issued more cautious 2026 expectations, trimmed its 2025 organic revenue growth outlook, and disc...

Zimmer Biomet Holdings Valuation After Cautious Outlook Cuts And Rising Legal And Demand Concerns
Simply Wall St 4d
How Investors May Respond To Zimmer Biomet Cautious 2026 Outlook And Executive Departure

Zimmer Biomet Holdings, Inc. recently outlined a cautious 2026 outlook at the J.P. Morgan Healthcare Conference and disclosed that named executive officer Mark...

How Investors May Respond To Zimmer Biomet Cautious 2026 Outlook And Executive Departure

People also own

Based on the portfolios of people who own ZBH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.